Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11464-11469

  Zhuang, Zhen ^a   Bai, Qiong ^b   Lata, A ^b   Liang, Yaoxian ^c   Zheng, Danxia ^b   Wang, Yue ^b  

^a TSINGHUA UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Albuminuria; Normotensive type 2 diabetic patients; Urinary angiotensinogen

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMINURIA; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; URINE;

ADULT; AGED; ALBUMINURIA; ANGIOTENSINOGEN; BIOMARKERS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 85013059389     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F and Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
3. Kobori H, Nangaku M, Navar LG and Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
4. Kobori H, Kamiyama M, Harrison-Bernard LM and Navar LG. Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med 2013; 61: 256-264.
5. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y and Nishiyama A. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005; 16: 703-711.
6. Kobori H, Harrison-Bernard LM and Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 2002; 61: 579-585.
7. Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F and Hishida A. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 1558-1565.
8. Kamiyama M, Zsombok A and Kobori H. Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci 2012; 119: 314-323.
9. Nakano D, Kobori H, Burford JL, Gevorgyan H, Seidel S, Hitomi H, Nishiyama A and Peti-Pe-Terdi J. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol 2012; 23: 1847-1856.
10. Kamiyama M, Urushihara M, Morikawa T, Konishi Y, Imanishi M, Nishiyama A and Kobori H. Oxidative stress/angiotensinogen/renin-angi-otensin system axis in patients with diabetic nephropathy. Int J Mol Sci 2013; 14: 23045-23062.
11. Singh R, Singh AK, Alavi N and Leehey DJ. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 2003; 14: 873-880.
12. Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H and Imanishi M. Urinary angiotensinogen reflects the activi-ty of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Tr-ansplant 2011; 26: 170-177.
13. Kim SM, Jang HR, Lee YJ, Lee JE, Huh WS, Kim DJ, Oh HY and Kim YG. Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease. Clin Nephrol 2011; 76: 117-123.
14. Jang HR, Lee YJ, Kim SR, Kim SG, Jang EH, Lee JE, Huh W and Kim YG. Potential role of urinary angiotensinogen in predicting antiproteinuric effects of angiotensin receptor blocker in non-diabetic chronic kidney disease patients: a preliminary report. Postgrad Med J 2012; 88: 210-216.
15. Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, Orscelik O, Sipahioglu MH, Tokgoz B and Oymak O. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease. Am J Nephrol 2013; 38: 218-225.
16. Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL and Navar LG. Urinary angiotensinogen as a novel biomarker of the intra-renal renin-angiotensin system status in hypertensive patients. Hypertension 2009; 53: 344-350.